TickerFactsScreenerDevelopers

Cocrystal Pharma, Inc. (COCP) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $587.4K2010: $251.5K2011: $35.4K2012: $4.72M2013: $1.03M2014: $3.97M2015: $9.28M2016: $3.60M2017: $748.0K2019: $7.42M2020: $33.01M2021: $58.70M2022: $37.14M2023: $26.35M2024: $9.86M2025: $7.03M$7.03M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$7.03M-28.8%
2024$9.86M-62.6%
2023$26.35M-29.1%
2022$37.14M-36.7%
2021$58.70M+77.8%
2020$33.01M+345.0%
2019$7.42M—
2017$748.0K-79.3%
2016$3.60M-61.1%
2015$9.28M+133.7%
2014$3.97M+283.9%
2013$1.03M-78.1%
2012$4.72M+13236.9%
2011$35.4K-85.9%
2010$251.5K-57.2%
2009$587.4K—